| Pharmaceutical Information |
| Drug Name |
Sacrosidase |
| Drug ID |
BADD_D01979 |
| Description |
Sacrosidase is a liquid enzyme preparation from S.cerevisiae used for the treatment of congenital sucrose-isomaltase deficiency (CSID). People with CSID have variable amounts of sucrose-isomaltase enzyme activity and therefore have issues metabolizing dietary disaccharide sucrose causing chronic or intermittent watery diarrhea in infants and children. Treatment options for these patients are limited and usually consists of a lifelong sucrose-free diet; therefore, sacrosidase offers a potential alternative for symptom relief. |
| Indications and Usage |
For the treatment of congenital sucrose-isomaltase deficiency (CSID). |
| Marketing Status |
approved |
| ATC Code |
A16AB06 |
| DrugBank ID |
DB06760
|
| KEGG ID |
D05782
|
| MeSH ID |
D043324
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
67871-111; 73301-007 |
| UNII |
8A7F670F2Y
|
| Synonyms |
beta-Fructofuranosidase | beta Fructofuranosidase | beta-D-Fructofuranosidase | beta D Fructofuranosidase | Sucrose 6-Phosphate Hydrolase | 6-Phosphate Hydrolase, Sucrose | Hydrolase, Sucrose 6-Phosphate | Sucrose 6 Phosphate Hydrolase | Invertase | Saccharase | Acid Invertase | Invertase, Acid | beta-Fructosidase | beta Fructosidase | Sucraid | Sacrosidase |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
85897-35-4 |
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
